Study With Vortioxetine on Emotional Functioning in Patients With Depression
Status:
Completed
Trial end date:
2020-02-21
Target enrollment:
Participant gender:
Summary
The study will evaluate effectiveness of flexible dose vortioxetine 10-20 mg/day on emotional
functioning in patients with MDD with an inadequate response to SSRIs/SNRIs.